Sleepless Nights Over EU Labeling Rule For Investigational Drugs
Rule requires inner packages of investigational products contain updated information about retest and expiration dates; small-sized products like blister packs and injectables are particularly problematic.
You may also be interested in...
This is an update of recommendations from the European Medicines Agency's Committee for Medicinal Products for Human Use on the authorization of new medicines in the European Union, and updates on EU marketing authorization changes recommended by the CHMP.
New medicines under evaluation at the European Medicines Agency.
The European Medicine Agency has recommended extending the therapeutic indication of a raft of drugs that are already authorized in the EU.